Skip to main content

SUBUNIDADES REGULADORAS DE CANALES DE CL- CLC Y SUS ENFERMEDADES ASOCIADAS LEUCOENCEFALOPATIA MEGALENCEFALICA Y SINDROME DE BARTTER

SAF2012-31486

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Investigación, Desarrollo e Innovación
Beneficiary centre UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes

  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Gradogna, Antonella
  • Laparra-Cuervo, Lara
  • Solsona, Carles
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Lakadamyali, Melike
  • Estévez, Raúl|||0000-0003-1579-650X
Volume-regulated anion channels (VRACs) play an important role in controlling cell volume by opening upon cell swelling. Recent work has shown that heteromers of LRRC8A with other LRRC8 members (B, C, D, and E) form the VRAC. Here, we used Xenopus oocytes as a simple system to study LRRC8 proteins. We discovered that adding fluorescent proteins to the C-terminus resulted in constitutive anion channel activity. Using these constructs, we reproduced previous findings indicating that LRRC8 heteromers mediate anion and osmolyte flux with subunit-dependent kinetics and selectivity. Additionally, we found that LRRC8 heteromers mediate glutamate and ATP flux and that the inhibitor carbenoxolone acts from the extracellular side, binding to probably more than one site. Our results also suggest that the stoichiometry of LRRC8 heteromers is variable, with a number of subunits ≥6, and that the heteromer composition depends on the relative expression of different subunits. The system described here enables easy structure-function analysis of LRRC8 proteins.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Megalencephalic leukoencephalopathy with subcortical cysts, A personal biochemical retrospective

  • Estévez, Raúl|||0000-0003-1579-650X
  • Elorza-Vidal, Xabier
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Pérez-Rius, Carla
  • Armand-Ugón, Mercedes|||0000-0002-4069-9915
  • Alonso-Gardón, Marta
  • Xicoy Espaulella, Efren
  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Arnedo, Tanit
  • Capdevila-Nortes, Xavier
  • López-Hernández, Tania
  • Montolio, Marisol|||0000-0001-5494-5737
  • Duarri, Anna|||0000-0003-4075-5478
  • Teijido, Oscar|||0000-0002-4600-6972
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
  • Palacín Prieto, Manuel|||0000-0002-8670-293X
  • Nunes Martínez, Virginia|||0000-0002-5747-9310
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by dysfunction of the role of glial cells in controlling brain fluid and ion homeostasis. Patients affected by MLC present macrocephaly, cysts and white matter vacuolation, which lead to motor and cognitive impairments. To date, there is no treatment for MLC, only supportive care. MLC is caused by mutations in the MLC1 and GLIALCAM genes. MLC1 is a membrane protein with low identity to the Kv1.1 potassium channel and GlialCAM belongs to an adhesion molecule family. Both proteins form a complex with an as-yet-unknown function that is expressed mainly in the astrocytes surrounding the blood-brain barrier and in Bergmann glia. GlialCAM also acts as an auxiliary subunit of the chloride channel ClC-2, thus regulating its localization at cell-cell junctions and modifying its functional properties by affecting the common gate of ClC-2. Recent studies in Mlc1-, GlialCAM- and Clcn2-knockout mice or Mlc1-knockout zebrafish have provided fresh insight into the pathophysiology of MLC and further details about the molecular interactions between these three proteins. Additional studies have shown that GlialCAM/MLC1 also regulates other ion channels (TRPV4, VRAC) or transporters (Na+/K+-ATPase) in a not-understood manner. Furthermore, it has been shown that GlialCAM/MLC1 may influence signal transduction mechanisms, thereby affecting other proteins not related with transport such as the EGF receptor. Here, we offer a personal biochemical retrospective of the work that has been performed to gain knowledge of the pathophysiology of MLC, and we discuss future strategies that may be used to identify therapeutic solutions for MLC patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification and Functional Characterization of CLCN1 Mutations Found in Nondystrophic Myotonia Patients

  • Vindas-Smith, Rebeca
  • Fiore, Michele
  • Vásquez, Melissa
  • Cuenca, Patricia
  • Del Valle, Gerardo
  • Lagostena, Laura
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Estévez, Raúl|||0000-0003-1579-650X
  • Pusch, Michael
  • Morales, Fernando
Mutations in the gene coding for the skeletal muscle Cl- channel (CLCN1) lead to dominant or recessive myotonia. Here, we identified and characterized CLCN1 mutations in Costa Rican patients, who had been clinically diagnosed with myotonic dystrophy type 1 but who were negative for DM1 mutations. CLCN1 mutations c.501C>G, p.F167L and c.1235A>C, p.Q412P appeared to have recessive inheritance but patients had atypical clinical phenotypes; c.313C>T, p.R105C was found in combination with c.501C>G, p.F167L in an apparently recessive family and the c.461A>G, p.Q154R variant was associated with a less clear clinical picture. In Xenopus oocytes, none of the mutations exhibited alterations of fast or slow gating parameters or single channel conductance, and mutations p.R105C, p.Q154R, and p.F167L were indistinguishable from wild-type (WT). p.Q412P displayed a dramatically reduced current density, surface expression and exerted no dominant negative effect in the context of the homodimeric channel. Fluorescently tagged constructs revealed that p.Q412P is expressed inefficiently. Our study confirms p.F167L and p.R105C as myotonia mutations in the Costa Rican population, whereas p.Q154R may be a benign variant. p.Q412P most likely induces a severe folding defect, explaining the lack of dominance in patients and expression systems, but has WT properties once expressed in the plasma membrane.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Megalencephalic leukoencephalopathy with subcortical cysts protein 1 regulates glial surface localization of GLIALCAM from fish to humans

  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Folgueiras López, Mónica
  • López-Hernández, Tania
  • Minier, Laura
  • Pérez-Rius, Carla
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Zang, Jingjing
  • Martínez, Albert
  • Capdevila-Nortes, Xavier
  • de la Villa, Pedro|||0000-0001-9856-6616
  • Roy, Upasana
  • Alia, A.
  • Neuhauss, Stephan
  • Ferroni, Stefano
  • Nunes Martínez, Virginia|||0000-0002-5747-9310
  • Estévez, Raúl|||0000-0003-1579-650X
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a leukodystrophy characterized by myelin vacuolization and caused by mutations in MLC1 or GLIALCAM. Patients with recessive mutations in either MLC1 or GLIALCAM show the same clinical phenotype. It has been shown that GLIALCAM is necessary for the correct targeting of MLC1 to the membrane at cell junctions, but its own localization was independent of MLC1 in vitro. However, recent studies in Mlc1(-/-) mice have shown that GlialCAM is mislocalized in glial cells. In order to investigate whether the relationship between Mlc1 and GlialCAM is species-specific, we first identified MLC-related genes in zebrafish and generated an mlc1(-/-) zebrafish. We have characterized mlc1(-/-) zebrafish both functionally and histologically and compared the phenotype with that of the Mlc1(-/-) mice. In mlc1(-/-) zebrafish, as in Mlc1(-/-) mice, Glialcam is mislocalized. Re-examination of a brain biopsy from an MLC patient indicates that GLIALCAM is also mislocalized in Bergmann glia in the cerebellum. In vitro, impaired localization of GlialCAM was observed in astrocyte cultures from Mlc1(-/-) mouse only in the presence of elevated potassium levels, which mimics neuronal activity. In summary, here we demonstrate an evolutionary conserved role for MLC1 in regulating glial surface levels of GLIALCAM, and this interrelationship explains why patients with mutations in either gene (MLC1 or GLIALCAM) share the same clinical phenotype.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Megalencephalic leukoencephalopathy with subcortical cysts: a personal biochemical retrospective

  • Estévez, Raúl
  • Elorza-Vidal, Xabier
  • Gaitán-Peñas, Héctor
  • Pérez-Rius, Carla
  • Armand-Ugón, Mercedes
  • Alonso-Gardón, Marta
  • Xicoy-Espaulella, Efren
  • Sirisi, Sònia
  • Arnedo, Tanit
  • Capdevila-Nortes, Xavier
  • López-Hernández, Tania
  • Montolio, Marisol
  • Duarri, Anna
  • Teijido Hermida, Óscar
  • Barrallo-Gimeno, Alejandro
  • Palacín, Manuel
  • Nunes, Virginia
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by dysfunction of the role of glial cells in controlling brain fluid and ion homeostasis. Patients affected by MLC present macrocephaly, cysts and white matter vacuolation, which lead to motor and cognitive impairments. To date, there is no treatment for MLC, only supportive care. MLC is caused by mutations in the MLC1 and GLIALCAM genes. MLC1 is a membrane protein with low identity to the Kv1.1 potassium channel and GlialCAM belongs to an adhesion molecule family. Both proteins form a complex with an as-yet-unknown function that is expressed mainly in the astrocytes surrounding the blood-brain barrier and in Bergmann glia. GlialCAM also acts as an auxiliary subunit of the chloride channel ClC-2, thus regulating its localization at cell-cell junctions and modifying its functional properties by affecting the common gate of ClC-2. Recent studies in Mlc1-, GlialCAM- and Clcn2-knockout mice or Mlc1-knockout zebrafish have provided fresh insight into the pathophysiology of MLC and further details about the molecular interactions between these three proteins. Additional studies have shown that GlialCAM/MLC1 also regulates other ion channels (TRPV4, VRAC) or transporters (Na+/K+-ATPase) in a not-understood manner. Furthermore, it has been shown that GlialCAM/ MLC1 may influence signal transduction mechanisms, thereby affecting other proteins not related with transport such as the EGF receptor. Here, we offer a personal biochemical retrospective of the work that has been performed to gain knowledge of the pathophysiology of MLC, and we discuss future strategies that may be used to identify therapeutic solutions for MLC patients., This work was supported in part by grants from the European Leukodystrophies Association (ELA) Research Foundation (ELA2012- 014C2B) to RE and VN, Ministerio de Ciencia e Innovación (SAF2012-31486 to RE and SAF2015-70377 to RE and ABG), Generalitat de Catalunya ((SGR2014-1178) to RE), (SGR2014-541) to VN)), Instituto de Salud Carlos III (bodies linked to MICINN and FEDER): (ERARE) to RE, FIS PI13/00121 to VN.